Results 211 to 220 of about 29,580 (292)

Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context [PDF]

, 2016
Harrison, Claire, McMullin, Mary Frances
core   +1 more source

Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication. [PDF]

Ther Adv Chronic Dis
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K.   +13 more
europepmc   +1 more source

Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial. [PDF]

J Clin Oncol
Mohty M, Socié G, Szer J, Niederwieser D, Butler J, Wagner-Drouet E, Or R, Rovenvald-Zuckerman T, Bozdag SC, Forcade E, Grillo G, Kröger N, Stölzel F, Russo D, Sanz J, Sarkar R, Stefanelli T, Wilke C, Zeiser R, von Bubnoff N.   +19 more
europepmc   +1 more source

Comparative Efficacy of Monotherapies for Chronic Hand Eczema: A Network Meta‐Analysis Study

Journal of Cosmetic Dermatology, Volume 24, Issue 12, December 2025.
ABSTRACT Introduction Chronic hand eczema (CHE) is a highly prevalent dermatology‐related occupational hazard. This condition, which is a distinct diagnosis from atopic dermatitis (AD), can be quite symptomatic with implications for one's personal and professional life.
Aditya K. Gupta, Mary A. Bamimore, Mesbah Talukder   +2 more
wiley   +1 more source

Corrigendum to Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease. [PDF]

J Clin Invest
Lin Y, Gu Q, Lu S, Pan Z, Yang Z, Li Y, Yang S, Lv Y, Zheng Z, Sun G, Gou F, Xu C, Zhao X, Wang F, Wang C, Yuan S, Xie X, Cao Y, Liu Y, Gu W, Cheng T, Cheng H, Hu X.   +22 more
europepmc   +1 more source

Supplementary Methods from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

Joe‐Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Léonard-Louis, Stéphane Éderhy, Alban Redheuil, Samia Boussouar, Lee S. Nguyen, Adrien Procureur, Frederic Stein, Charlotte Fenioux, Perrine Devos, Paul Gougis, Martin Dres, Alexandre Demoule, Dimitri Psimaras, Timothée Lenglet, Thierry Maisonobe, Marc Pineton de Chambrun, Guillaume Hékimian, Christian Straus, Jésus González-Bermejo, David Klatzmann, A. Rigolet, Perrine Guillaume-Jugnot, Nicolas Champtiaux, Olivier Benvéniste, Nicolas Weiss, Samir Saheb, Philippe Rouvier, Isabelle Plu, Estelle Gandjbakhch, Mathieu Kerneïs, Nadjib Hammoudi, Noël Zahr, Claudia Llontop, Capucine Morélot‐Panzini, Lorenz Lehmann, Juan Qin, Javid J. Moslehi, Michèlle Rosenzwajg, Thomas Similowski, Yves Allenbach   +42 more
openalex   +1 more source

Hemophagocytic Lymphohistiocytosis in a Pediatric Lung Transplant Recipient

Pediatric Transplantation, Volume 29, Issue 8, December 2025.
ABSTRACT Background Hemophagocytic lymphohistiocytosis (HLH) is a rare complication of solid organ transplantation and is a syndrome of systemic hyperinflammation secondary to dysregulation of the inflammatory response, primarily involving lymphocytes and macrophages. It is often fatal and therefore early recognition and treatment are crucial. Among 11
Sunil Chickmagalur, Anna Schrader, Dallas Parrish, David Moreno McNeill, Maria C. Gazzaneo, Ernestina Melicoff‐Portillo, Nahir Cortes‐Santiago   +6 more
wiley   +1 more source

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies [PDF]

, 2014
DiPersio, John F, et al,
core   +1 more source

Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model. [PDF]

Blood Cancer J
Tavernari L, Bertesi M, Neroni A, Papa E, Rontauroli S, Bianchi E, Mirabile M, Norfo R, Parenti S, Tombari C, Carretta C, Malerba M, Fabbiani L, Guglielmelli P, Losi L, Tagliafico E, Vannucchi AM, Manfredini R, MYNERVA (MYeloid NEoplasms Research Venture AIRC) investigators.   +18 more
europepmc   +1 more source

Role of ruxolitinib in preventing cardiac arrhythmias: A pooled analysis of clinical studies in hematology. [PDF]

Int J Cardiol Heart Vasc
Zaoli S, Khatri M, Holzhauer B, Peyrard S, Ferreira A, Stefanelli T.   +5 more
europepmc   +1 more source